These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 10672127)

  • 41. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise.
    Eriksson KF; Lindgärde F
    Diabetologia; 1998 Sep; 41(9):1010-6. PubMed ID: 9754818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa.
    Egeberg A; Gislason GH; Hansen PR
    JAMA Dermatol; 2016 Apr; 152(4):429-34. PubMed ID: 26885728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lifestyle and 15-year survival free of heart attack, stroke, and diabetes in middle-aged British men.
    Wannamethee SG; Shaper AG; Walker M; Ebrahim S
    Arch Intern Med; 1998 Dec 7-21; 158(22):2433-40. PubMed ID: 9855381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
    Hellquist BN; Czene K; Hjälm A; Nyström L; Jonsson H
    Cancer; 2015 Jan; 121(2):251-8. PubMed ID: 25242087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Morbidity and mortality risk among patients with screening-detected severe hypertension in the Malmö Preventive Project.
    Westerdahl C; Zöller B; Arslan E; Erdine S; Nilsson PM
    J Hypertens; 2014 Dec; 32(12):2378-84; discussion 2384. PubMed ID: 25202881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
    Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
    J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Risk factors smoking, serum cholesterol and blood pressure analyzed. Excess risk also in the "moderate" groups].
    Wilhelmsen L; Rosengren A
    Lakartidningen; 2002 Dec; 99(49):4966-73. PubMed ID: 12522986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.
    Adamsson Eryd S; Gudbjörnsdottir S; Manhem K; Rosengren A; Svensson AM; Miftaraj M; Franzén S; Björck S
    BMJ; 2016 Aug; 354():i4070. PubMed ID: 27492939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Geographical pattern of female deaths from myocardial infarction in an urban population: fatal outcome out-of-hospital related to socio-economic deprivation.
    Tydén P; Engström G; Hansen O; Hedblad B; Janzon L
    J Intern Med; 2001 Sep; 250(3):201-7. PubMed ID: 11555123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The disparity in long-term survival after a first stroke in patients with and without diabetes persists: the Northern Sweden MONICA study.
    Eriksson M; Carlberg B; Eliasson M
    Cerebrovasc Dis; 2012; 34(2):153-60. PubMed ID: 22907276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.
    Keech A; Colquhoun D; Best J; Kirby A; Simes RJ; Hunt D; Hague W; Beller E; Arulchelvam M; Baker J; Tonkin A;
    Diabetes Care; 2003 Oct; 26(10):2713-21. PubMed ID: 14514569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonattendance in mammographic screening: a study of intraurban differences in Malmö, Sweden, 1990-1994.
    Matson S; Andersson I; Berglund G; Janzon L; Manjer J
    Cancer Detect Prev; 2001; 25(2):132-7. PubMed ID: 11341348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of screening for breast cancer in women under 50 years at entry: the Kotka pilot project in Finland.
    Hakama M; Pukkala E; Kallio M; Godenhjelm K; Svinhufvud U
    Int J Cancer; 1995 Sep; 63(1):55-7. PubMed ID: 7558452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of body fatness and physical activity on cardiovascular risk: risk prediction using the bioelectrical impedance method.
    Calling S; Hedblad B; Engström G; Berglund G; Janzon L
    Scand J Public Health; 2006; 34(6):568-75. PubMed ID: 17132589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes.
    Hero C; Rawshani A; Svensson AM; Franzén S; Eliasson B; Eeg-Olofsson K; Gudbjörnsdottir S
    Diabetes Care; 2016 Jun; 39(6):996-1003. PubMed ID: 27208327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial.
    Frisell J; Lidbrink E; Hellström L; Rutqvist LE
    Breast Cancer Res Treat; 1997 Sep; 45(3):263-70. PubMed ID: 9386870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.
    Uusitupa MI; Niskanen LK; Siitonen O; Voutilainen E; Pyörälä K
    Diabetologia; 1993 Nov; 36(11):1175-84. PubMed ID: 8270133
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.